Publications

5539 Results

Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: An Eastern Cooperative Oncology Group study (2192)

Authors
DL Page;R Gray;DC Allred;LG Dressler;AK Hatfield;S Martino;NJ Robert;WC Wood
Journal / Conference
American Journal of Clinical Oncology 24(1):10-18
Year
2001
Research Committee(s)
Breast

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)

Authors
O Kucuk;E Fisher;CM Moinpour;D Coleman;MHA Hussain;AO Sartor;GS Chatta;BA Lowe;MA Eisenberger;ED Crawford
Journal / Conference
Urology 58(1):53-58
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9235

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials

Authors
JM Unger;LE Flaherty;PY Liu;KS Albain;VK Sondak
Journal / Conference
Cancer 91(6):148-1155
Year
2001
Research Committee(s)
Gynecologic and Melanoma
Study Number(s)
SWOG-8107, SWOG-8118, SWOG-8240, SWOG-8324, SWOG-8562, SWOG-8569, SWOG-8723, SWOG-8754, SWOG-8804, SWOG-8913, SWOG-8921, SWOG-9116, SWOG-9223, SWOG-9228, SWOG-9238 (INT-0134) (GOG-134) (NCCTG-92-61-51)

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: a Southwest Oncology Group trial (SWOG-9407)

Authors
KJ Pienta;EI Fisher;MA Eisenberger;GM Mills;JW Goodwin;JA Jones;SR Dakhil;ED Crawford;MHA Hussain
Journal / Conference
The Prostate 46:257-261
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9407

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma. a Southwest Oncology Group study

Authors
ER Gaynor;JM Unger;TP Miller;TM Grogan;LA White Jr;GM Mills;SP Balcerzak;M Varterasian;M LeBlanc;RI Fisher
Journal / Conference
Journal of Clinical Oncology 19(3):750-755
Year
2001
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9125, SWOG-9240

Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group Clinical Trial

Authors
CL Bennett;D Hynes;J Godwin;TJ Stinson;RM Golub;FR Appelbaum
Journal / Conference
Cancer Investigation 19(6):603-610
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia. a Southwest Oncology Group study

Authors
AF List;KJ Kopecky;CL Willman;DR Head;DL Persons;ML Slovak;R Dorr;C Karanes;HE Hynes;JH Doroshow;M Shurafa;FR Appelbaum
Journal / Conference
Blood 98(12):3212-3220
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9126

Association of African American ethnic background with survival in men with metastatic prostate cancer.

Authors
IM Thompson;CM Tangen;A Tolcher;ED Crawford;M Eisenberger;CM Moinpour
Journal / Conference
Journal of the National Cancer Institute 93(3):219-225
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis

Authors
SM Garrido;JJ Cooper;FR Appelbaum;CL Willman;K Kopecky;DE Banker
Journal / Conference
Leukemia Research 25:23-32
Year
2001
Research Committee(s)
Leukemia

Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group study

Authors
MHA Hussain;TR Glass;J Forman;W Sakr;DC Smith;M Al-Sarraf;J Jones;SP Balcerzak;ED Crawford;HB Grossman
Journal / Conference
Journal of Urology 165:56-61
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9312